4/A: MaxLinear Director RSU Grant Corrected

MaxLinear Director Greg Dougherty's restricted stock unit grant was amended to correct the reported number to 15,741 units.

Summary

• Greg Dougherty, a Director at MaxLinear, Inc. (MXL), had his Restricted Stock Unit (RSU) grant amended.
• The amendment corrects the number of RSUs previously reported in a Form 4 filed on May 22, 2025.
• The corrected number of RSUs granted is 15,741.
• Each RSU represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
• The RSUs will vest 100% on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, subject to Mr. Dougherty's continued directorship.

Sentiment

Score: 5

Explanation: This filing is a neutral administrative correction of a previously reported insider transaction. It does not contain new material information that would significantly impact the company's financial performance or strategic direction.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, encouraging long-term value creation.
• The company is transparent in correcting errors in its SEC filings, demonstrating adherence to regulatory requirements.

Negatives

• An initial error in reporting the number of RSUs required an amendment, indicating a minor administrative oversight.

Risks

• The vesting of the 15,741 RSUs is contingent upon the reporting person's continued service as a Director through the vesting date.

Future Outlook

The 15,741 Restricted Stock Units are scheduled to vest 100% on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, provided the director remains in service.

Industry Context

This filing represents a routine insider transaction amendment, common across all industries for publicly traded companies, reflecting equity compensation for board members and the necessary regulatory disclosures.

Stakeholder Impact

• Shareholders: The correction provides accurate disclosure regarding director equity compensation, reinforcing transparency. The grant itself aligns director incentives with shareholder value.

Next Steps

• The RSUs will vest according to the specified schedule, contingent on continued directorship.

Key Dates

Recommendation

This filing is an amendment to correct a previously reported insider transaction and does not contain new material information that would alter the investment thesis for MaxLinear, Inc. The correction of a director's RSU grant is a routine administrative matter and does not warrant a change in investment recommendation based solely on this document.

Keywords

MaxLinear, MXL, SEC filing, Form 4/A, Restricted Stock Units, RSU, Director, Equity Compensation, Insider Transaction, Amendment